Articles tagged "Outcome"

2018 American Transplant Congress
Evolutive Analysis of a 20-Year Pancreas Transplant Program
M. Perosa,¹ J. Branez,¹ L. Mota,¹ H. Noujaim,¹ B. Zeballos,¹ L. Ianhez,¹ L. Alvim,¹ D. Machado,¹ C. Watanabe,¹ F. Sergi,¹ M. Paredes,¹ T. Genzini-Miranda,² A. Silvestre,³ G. Martinho,⁴ T. Genzini.¹
¹Abdominal Organ Transplantation, Leforte Hospital, Sao Paulo, Brazil; ²Medical School, PUC Sorocaba, Sorocaba, Sao Paulo, Brazil; ³Medical School, Sao Camilo, Sao Paulo, Brazil; ⁴Medical School, Ciências Médicas Santa Casa, Sao Paulo, Brazil.
There is a worldwide trend towards a reduction in the annual number of pancreas transplants (PT). In Brazil, only two centers have performed more than…
2018 American Transplant Congress
Two Decades of Eurotransplant Senior Program (ESP): Time on Dialysis Independently Impacts Patient Survival, Allograft Survival and Quality of Life after Kidney Transplantation
T. Schachtner,^1,2,3 N. Otto,¹ P. Reinke.^1,2
¹Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; ²Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charite Campus Virchow Clinic, Berlin, Germany; ³Berlin Institute of Health (BIH), Charite and Max Delbrueck Center, Berlin, Germany.
In 1999, the Eurotransplant Senior Program (ESP) was implemented and allocates kidneys from deceased-donors ≥65 years to kidney transplant recipients ≥65 years (ESP-KTRs). The ESP…
2018 American Transplant Congress
Large Volume Intraoperative Fluid Use in Small (<20kg) Renal Recipients is Safe
N. Liow,¹ N. Mudalige,² N. Melhem,¹ S. Boyle,¹ N. Kessaris,¹ H. Hume-Smith,¹ S. Marks,¹ N. Mamode,¹ J. Stojanovic.¹
¹Paediatric Nephrology Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; ²University College London, London, United Kingdom.
INTRODUCTION: With advances in surgical and medical transplantation, progressively younger children are being transplanted. There is no consensus and little evidence on the optimal intraoperative…
2018 American Transplant Congress
Patients Prioritize Waitlist Factors over Outcomes When Evaluating Kidney Transplant Centers
A. Michelson, C. Brennan, A. Mattoo, B. Kil, D. Tsapepas, S. Husain, S. Mohan.
Nephrology, Columbia University Medical Center, New York, NY.
The factors that influence transplant candidates' selection of a transplant center for waitlisting are not well understood. Further, the relative weightage of these factors has…
2018 American Transplant Congress
Excellent Outcomes for HCV-Viremic Recipients of Simultaneous Liver-Kidney Transplant in the Direct Anti-Viral Era
A. Ray, C. Klein, T. Ommert, R. Cross, R. Rubin.
Piedmont Transplant Institute, Piedmont Healthcare, Atlanta, GA.
Before the era of direct anti-viral agents (DAAs), outcomes for HCV-viremic recipients of simultaneous liver kidney transplant (SLKT) were inferior to HCV-negative recipients. PURPOSE: To…
2018 American Transplant Congress
Prevalence and Infection-Related Outcomes Associated with Transplant Tourism
J. Slomovic, S. Humar, D. Kumar, A. Humar.
Transplant Infectious Diseases, Toronto General Hospital, Toronto, ON, Canada.
Background:Patients who receive organ transplants via transplant tourism may have a greater risk of complications. We sought to describe the infectious risks associated with this…
2018 American Transplant Congress
APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO)
G. Guerra,¹ E. Poggio,² M. Ortigosa-Goggins,¹ M. Doshi,³ B. Freedman,⁴ D. Reboussin,⁴ P. Kimmel,⁵ APOLLO Investigators.
¹Miami Transplant Institute, Miami, FL; ²Cleveland Clinic, Cleveland, OH; ³University of Michigan, Ann Arbor, MI; ⁴Wake Forest School of Medicine, Winston-Salem, NC; ⁵NIDDK, Bethesda, MD.
Two renal-risk variants in the apolipoprotein L1 gene (APOL1) are powerfully associated with a spectrum of non-diabetic chronic kidney diseases in populations with recent African…
2018 American Transplant Congress
Variation in Hypothermic Machine Perfusion Utilization and Clinical Outcomes for Deceased-Donor Kidneys
V. Krishnamoorthy,¹ S. Wunsch,² K. O'Connor,² M. Souter.³
¹Anesthesiology, Duke University, Durham, NC; ²LifeCenter Northwest, Bellevue, WA; ³Anesthesiology and Pain Medicine, University of Washington, Seattle, WA.
Introduction:Hypothermic machine perfusion (HMP) has been shown to be an effective method for preserving kidney allografts from deceased donors (1), but data suggests that low-risk…
2018 American Transplant Congress
The THINKER Trial: Quality of Life Results at 6- and 12-Month Follow-Up among Hepatitis C-Negative Patients Who Received Kidney Transplants from Deceased Donors with Hepatitis C Infection
V. Potluri, D. Goldberg, A. Peter, B. Emily, B. Roy, S. Deirdre, M. Levine, J. Trofe-Clark, M. Bleicher, S. Goral, A. Sicilia, S. Nazarian, R. Reddy, P. Porrett, P. Reese.
Univ of Pennsylvania, Philadelphia, PA.
Background: Short-term (6-month) data from the first 10 subjects in the pilot THINKER-1 trial (NCT02743897; funder: Merck) suggested that kidneys from HCV-infected donors could be…
2018 American Transplant Congress
Outcomes after HIV+ Kidney Transplant: A HOPE in Action Study
C. Durand,¹ M. Bowring,¹ A. Tobian,¹ D. Brown,¹ N. Desai,¹ S. Bagnasco,¹ D. Ostrander,¹ A. Redd,¹ S. Huprikar,² B. Haydel,² S. Lerner,² S. Florman,² S. Chandran,³ A. Chao,³ J. Locke,⁴ S. Mehta,⁴ R. Freidman,⁵ N. Turgeon,⁵ A. Massie,¹ D. Segev.¹
¹JHU, Baltimore, MD; ²Mount Sinai, New York, NY; ³UCSF, San Francisco, CA; ⁴UAB, Birmingham; ⁵Emory, Atlanta.
The HIV Organ Policy Equity (HOPE) Act allows HIV-infected donor (HIV D+) organs to be transplanted into HIV+ recipients (HIV R+) under research protocols. We…